Cyproheptadine Indications and Usage

Primary Indications

The American Academy of Pediatrics recommends cyproheptadine as a first-generation H1-antihistamine for treating allergic-type symptoms and rhinorrhea in adults and pediatric patients aged 2 years and older, with common dosing being 4 mg three times daily in adults and 2 mg/5 mL syrup available for pediatric patients 1
Cyproheptadine provides better control of rhinorrhea compared to second-generation antihistamines due to its anticholinergic effects 1
First-generation antihistamines like cyproheptadine cause significant sedation, impair driving ability, and can lead to cognitive decline, particularly in elderly patients, with a sedation incidence of 9-11% 1

Cyproheptadine is the preferred antidote for severe serotonin syndrome, functioning as a serotonin2A receptor antagonist, with adult dosing starting at 12 mg orally, followed by 2 mg every 2 hours for continuing symptoms, and maintenance dosing of 8 mg every 6 hours 2, 3
The American Academy of Pediatrics specifically recommends cyproheptadine over chlorpromazine for severe serotonin syndrome cases 2, 3
Pediatric dosing for serotonin syndrome is 0.25 mg/kg per day, and critical consideration should be given to the lack of a parenteral form, although tablets can be crushed and administered via nasogastric tube 2, 3
Serotonin syndrome has an 11% mortality rate, with complications including rhabdomyolysis, metabolic acidosis, renal failure, and seizures, and requires ICU-level monitoring with preparation for rapid deterioration 2, 4

Cyproheptadine is recommended for gastrointestinal symptoms in Mast Cell Activation Syndrome (MCAS) due to its dual H1-antihistamine and antiserotonergic properties, and may help with diarrhea and nausea specifically 5, 6
The mechanism of cyproheptadine in MCAS involves blocking both histamine H1 receptors and serotonin receptors, providing broader symptom control than standard antihistamines 5, 6

The American Academy of Sleep Medicine position paper addresses cyproheptadine for combat-related nightmares, with dosing ranges from 2-24 mg nightly, and median effective doses of 16-24 mg in veterans 7
Evidence for cyproheptadine in PTSD-related nightmares is conflicting, with one case series showing elimination of nightmares in 3 of 4 patients within days, while another study of 16 patients showed no significant improvement 7

Cognitive decline risk is especially concerning in elderly patients due to anticholinergic effects, and may impair driving ability and school performance even without subjective awareness of sedation 1, 5, 6
Anticholinergic effects of cyproheptadine include dry mouth, dry eyes, constipation, urinary retention, and risk of narrow-angle glaucoma 1
Concomitant use with alcohol and other CNS-active substances should be avoided, as it enhances performance impairment 1
In serotonin syndrome, indirect sympathomimetics like dopamine should be avoided, and direct-acting agents like phenylephrine and norepinephrine should be used instead 2, 3
Monitoring requirements for serotonin syndrome include ICU-level monitoring with preparation for rapid deterioration, intubation, and paralysis with non-depolarizing agents if needed, and avoiding succinylcholine due to hyperkalemia and rhabdomyolysis risks 2, 4